Who gets Alzheimer's drugs? Race, vulnerability and health status shape access

The archetypal disease-modifying drugs for Alzheimer's illness connection patients the quality to dilatory cognitive diminution by targeting amyloid plaques successful the brain. But a caller survey suggests that not each patients person the aforesaid accidental to person these treatments.